Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Exploiting phage to detect Mycobacteria – things you discover when you don’t know not to look

Reported by Dr Catherine Rees at Viruses of Microbes 2016 Conference.
  • July 26, 2016
  • Research
  • event, technology
PBD Biotech - blood tests

Mycobacteria are responsible for a number of important human and animal infections. One particular problem posed by these organisms when using molecular methods is the physical strength of the cell wall, so that sensitivity of detection is limited by the efficiency of DNA extraction.

Over the last 15 years we have been exploiting a broad host range, lytic phage (D29) as a DNA lysing agent to develop rapid and sensitive tests to detect and identify mycobacterial pathogens.

In addition to being very efficient at lysing mycobacteria, phage have another advantage over chemical extraction methods in that only viable cells are lysed, and therefore successful lysis using phage also reports on the viability of the cell detected.

We have now developed a method that can successfully detect mycobacteria within 6 h, and have applied this to a number of different samples. During these studies we have discovered new features of the phage-host interaction that has allowed us to better understand and improve our test methods.

Most recently we have used the method to show that viable M. bovis is present in the blood of skin-test positive cattle, despite the fact that the dogma of the disease suggests it should not be present. In addition we are now using this method to improve detection and control of bovine TB in naturally infected herds in the UK.

The method developed is simple and can be applied to detect any mycobacteria in a range of different sample types, opening up the possibility of an enhanced understanding of these difficult to grow bacteria.

Share:

Related posts

Loading...
Tomas Richardson

Disruptive phage technology attracts top scientist to PBD Biotech

January 18, 2022
“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis” says Dr Tomas Richardson.
Tomas Richardson

Disruptive phage technology attracts top scientist to PBD Biotech

January 18, 2022
“PBD Biotech has developed an exciting and potentially disruptive technology that uses bacteriophage to improve the molecular diagnosis of tuberculosis”...
huynh-phg21-poster-final-web

Multiplicity of infection – Albert Huynh presents research at Phages 2021

September 22, 2021
Albert’s research, ‘Use of 2, 3, 5-Triphenyltetrazolium chloride (TTC) to assay the kinetics of phage and host interactions’, is sponsored by PBD Biotech through the BBSRC CASE initiative, and was co-authored by fellow Nottingham student Philip J. Hill and PBD...
huynh-phg21-poster-final-web

Multiplicity of infection – Albert Huynh presents research at Phages 2021

September 22, 2021
Albert’s research, ‘Use of 2, 3, 5-Triphenyltetrazolium chloride (TTC) to assay the kinetics of phage and host interactions’, is sponsored...
cow

Study showing prevalence of cow-to-cow TB transmission emphasises need for more accurate diagnostic

December 18, 2019
New research about the transmission of bovine TB, published in the journal eLife this week, shows that the chance of cross infection between cows is much greater than between badgers and cows, with TB passing between members of the same...
cow

Study showing prevalence of cow-to-cow TB transmission emphasises need for more accurate diagnostic

December 18, 2019
New research about the transmission of bovine TB, published in the journal eLife this week, shows that the chance of...

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More